SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
Monoclonal gammopathy of undetermined significance
Monoclonal gammopathy, NOS
Monoclonal gammopathy, unassociated
Monoclonal gammopathy, unattributed
MGUS is defined as the presence in the serum of an M-protein < 30 g/L, bone marrow clonal plasma cells < 10%, no end organ damage, and no evidence of B-cell lymphoma or other disease known to produce an M-protein. MGUS is considered a pre-neoplastic condition.